← Insider buys

Judy D. Olian bought stock once, on Feb 20, 2026

Director at United Therapeutics Corporation, and 1 other company

SEC CIK 0001605729 · Filings on SEC.gov ↗

$60KBought
$11.0MSold
Feb 24Last buy

Judy D. Olian's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

19 filings since Jun 2018, newest first

About Judy D. Olian

Dr. Judy D. Olian is a Director at Ares Management Corporation (ARES), a position she has held since April 30, 2014.( As a corporate insider, she has recently engaged in trading activities at the firm.[user query context] Born and raised in Australia, Dr. Olian is President Emeritus of Quinnipiac University, having served as President from 2018 to 2025.(

Dr. Olian has a distinguished career in higher education leadership, including as Dean of the UCLA Anderson School of Management and John E. Anderson Chair in Management (2006-2018), Dean and Professor of Management at Pennsylvania State University's Smeal College of Business (2001-2006), and various roles at the University of Maryland's Robert H. Smith School of Business.( Her expertise focuses on organizational design, human resource systems, incentives, and top management teams.( She serves on boards including United Therapeutics Corporation (since 2015), Mattel, Inc., Hartford HealthCare, and others, and was Chair of AACSB International.( Dr. Olian holds a B.S. in Psychology from Hebrew University, Jerusalem, and M.S. and Ph.D. in Industrial Relations from University of Wisconsin-Madison.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.